Pharma Reaps Billions Off Orphan Drug Designations, Says New Report By Dutch Investigative Group 30/07/2020 Svĕt Lustig Vijay Big pharma has reaped billions in profit off the back of European orphan drug regulations that are supposed to incentivize R&D for rare diseases, according to an analysis of 120 orphan medicines registered in the EU over the past two decades. Instead of incentivizing R&D for rare maladies, the EU’s orphan drug legislation has turned […] Continue reading -> World Health Assembly Resolution On COVID-19 Response: The Stark Choices Faced In A Polarized World Of Global Health 08/05/2020 Svĕt Lustig Vijay & Elaine Ruth Fletcher As the 73rd World Health Assembly approaches, the European Union-sponsored draft resolution on the COVID-19 response is gathering steam and storm as it rolls closer to the planned opening of the Assembly on 18 May – with far less clarity about how it might actually hit the shores of the public debate. The resolution aims […] Continue reading -> Health Experts Welcome Sudan Move To Criminalize Female Genital Mutilation; But Legislation Is Not Enough To End Practice 01/05/2020 Svĕt Lustig Vijay Women’s and children’s health advocates have lauded a landmark move by Sudan to finally criminalize the practice of female genital mutilation and cutting (FGM/C) – punishing perpetrators for up to 3 years in prison to ward them off the crime. Last Thursday, Sudan’s National Council for Child Welfare endorsed a long-awaited amendment to Criminal Law […] Continue reading -> More People In Low- and Middle-Income Countries Are Obese – While Others Remain Undernourished 16/12/2019 Grace Ren More than one-third of low- and middle-income countries worldwide are facing significant rates of obesity alongside continued pockets of undernutrition, according to a major new study published on Monday in The Lancet. The four-part series The Double Burden of Malnutrition, led by the World Health Organization in collaboration with a number of universities and researchers […] Continue reading -> Cancer Organizations Across Latin America Vow To Intensify Action Against Expected “Tsunami” Of New Cancer Deaths 05/12/2019 Editorial team For the first time ever, leading cancer organizations across Latin America have signed onto a joint declaration pledging to intensify action against millions of avoidable cancer deaths on the continent. The Bogota Statement on Leading BOLD Cancer Prevention into the Future was signed by leaders of cancer organizations and foundations from 8 Latin American countries, […] Continue reading -> Civil Society Takes Charge On Climate Action As Governments Waver 21/09/2019 Elaine Ruth Fletcher NEW YORK CITY – Youth leaders from around the world clamored for more action on climate change Saturday at a first-ever United Nation’s Youth Climate Summit – even as the actual government commitments lined up for Monday’s formal meeting with heads of state appeared likely fall far short of making the dramatic changes that scientists […] Continue reading -> How To Fix The Medical R&D Model 14/08/2019 David Branigan Fifa Rahman, Unitaid NGO Delegation board member and PhD Candidate at the University of Leeds, moderated a panel at the recent IAS Conference on HIV Science in Mexico entitled “How To Fix Our Medical R&D Model: A Spotlight On TB Treatment.” The panel featured speakers from Médecins Sans Frontières’ (MSF/Doctors Without Borders) Access Campaign, Drugs […] Continue reading -> New Cancer Drugs Top Entries On WHO Essential Medicines List 09/07/2019 Editorial team, Elaine Ruth Fletcher & David Branigan WHO has added ten new cancer drugs, including some pricey ones, to its 2019 Essential Medicines List, which provides global guidance to countries and health systems about drugs deemed most essential to patients and public health systems. The addition of major new cancer treatments in five categories, melanoma (skin), lung, blood and prostate cancers, reflects […] Continue reading -> Major R&D Funding Needed To Reach 2030 Goal For Ending TB Epidemic 17/06/2019 Catherine Saez Nine months after a historic high-level UN meeting where countries pledged to end the global tuberculosis epidemic by 2030, a chronic lack of R&D financing jeopardises that ambitious goal, said expert panelists at a briefing on the TB R&D landscape last week in Geneva, hosted by South Africa’s Permanent Mission to the UN. While there […] Continue reading -> Draft UHC Declaration Strong On R&D Transparency, Weak On R&D Incentives Reform 14/06/2019 David Branigan In the lead-up to the United Nations High-Level Meeting on Universal Health Coverage (UHC) in September, the latest draft of a planned political declaration calls on member states to increase transparency of the cost of research and development (R&D) – in addition to drug prices – but falls short in the area of R&D incentive […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
World Health Assembly Resolution On COVID-19 Response: The Stark Choices Faced In A Polarized World Of Global Health 08/05/2020 Svĕt Lustig Vijay & Elaine Ruth Fletcher As the 73rd World Health Assembly approaches, the European Union-sponsored draft resolution on the COVID-19 response is gathering steam and storm as it rolls closer to the planned opening of the Assembly on 18 May – with far less clarity about how it might actually hit the shores of the public debate. The resolution aims […] Continue reading -> Health Experts Welcome Sudan Move To Criminalize Female Genital Mutilation; But Legislation Is Not Enough To End Practice 01/05/2020 Svĕt Lustig Vijay Women’s and children’s health advocates have lauded a landmark move by Sudan to finally criminalize the practice of female genital mutilation and cutting (FGM/C) – punishing perpetrators for up to 3 years in prison to ward them off the crime. Last Thursday, Sudan’s National Council for Child Welfare endorsed a long-awaited amendment to Criminal Law […] Continue reading -> More People In Low- and Middle-Income Countries Are Obese – While Others Remain Undernourished 16/12/2019 Grace Ren More than one-third of low- and middle-income countries worldwide are facing significant rates of obesity alongside continued pockets of undernutrition, according to a major new study published on Monday in The Lancet. The four-part series The Double Burden of Malnutrition, led by the World Health Organization in collaboration with a number of universities and researchers […] Continue reading -> Cancer Organizations Across Latin America Vow To Intensify Action Against Expected “Tsunami” Of New Cancer Deaths 05/12/2019 Editorial team For the first time ever, leading cancer organizations across Latin America have signed onto a joint declaration pledging to intensify action against millions of avoidable cancer deaths on the continent. The Bogota Statement on Leading BOLD Cancer Prevention into the Future was signed by leaders of cancer organizations and foundations from 8 Latin American countries, […] Continue reading -> Civil Society Takes Charge On Climate Action As Governments Waver 21/09/2019 Elaine Ruth Fletcher NEW YORK CITY – Youth leaders from around the world clamored for more action on climate change Saturday at a first-ever United Nation’s Youth Climate Summit – even as the actual government commitments lined up for Monday’s formal meeting with heads of state appeared likely fall far short of making the dramatic changes that scientists […] Continue reading -> How To Fix The Medical R&D Model 14/08/2019 David Branigan Fifa Rahman, Unitaid NGO Delegation board member and PhD Candidate at the University of Leeds, moderated a panel at the recent IAS Conference on HIV Science in Mexico entitled “How To Fix Our Medical R&D Model: A Spotlight On TB Treatment.” The panel featured speakers from Médecins Sans Frontières’ (MSF/Doctors Without Borders) Access Campaign, Drugs […] Continue reading -> New Cancer Drugs Top Entries On WHO Essential Medicines List 09/07/2019 Editorial team, Elaine Ruth Fletcher & David Branigan WHO has added ten new cancer drugs, including some pricey ones, to its 2019 Essential Medicines List, which provides global guidance to countries and health systems about drugs deemed most essential to patients and public health systems. The addition of major new cancer treatments in five categories, melanoma (skin), lung, blood and prostate cancers, reflects […] Continue reading -> Major R&D Funding Needed To Reach 2030 Goal For Ending TB Epidemic 17/06/2019 Catherine Saez Nine months after a historic high-level UN meeting where countries pledged to end the global tuberculosis epidemic by 2030, a chronic lack of R&D financing jeopardises that ambitious goal, said expert panelists at a briefing on the TB R&D landscape last week in Geneva, hosted by South Africa’s Permanent Mission to the UN. While there […] Continue reading -> Draft UHC Declaration Strong On R&D Transparency, Weak On R&D Incentives Reform 14/06/2019 David Branigan In the lead-up to the United Nations High-Level Meeting on Universal Health Coverage (UHC) in September, the latest draft of a planned political declaration calls on member states to increase transparency of the cost of research and development (R&D) – in addition to drug prices – but falls short in the area of R&D incentive […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Health Experts Welcome Sudan Move To Criminalize Female Genital Mutilation; But Legislation Is Not Enough To End Practice 01/05/2020 Svĕt Lustig Vijay Women’s and children’s health advocates have lauded a landmark move by Sudan to finally criminalize the practice of female genital mutilation and cutting (FGM/C) – punishing perpetrators for up to 3 years in prison to ward them off the crime. Last Thursday, Sudan’s National Council for Child Welfare endorsed a long-awaited amendment to Criminal Law […] Continue reading -> More People In Low- and Middle-Income Countries Are Obese – While Others Remain Undernourished 16/12/2019 Grace Ren More than one-third of low- and middle-income countries worldwide are facing significant rates of obesity alongside continued pockets of undernutrition, according to a major new study published on Monday in The Lancet. The four-part series The Double Burden of Malnutrition, led by the World Health Organization in collaboration with a number of universities and researchers […] Continue reading -> Cancer Organizations Across Latin America Vow To Intensify Action Against Expected “Tsunami” Of New Cancer Deaths 05/12/2019 Editorial team For the first time ever, leading cancer organizations across Latin America have signed onto a joint declaration pledging to intensify action against millions of avoidable cancer deaths on the continent. The Bogota Statement on Leading BOLD Cancer Prevention into the Future was signed by leaders of cancer organizations and foundations from 8 Latin American countries, […] Continue reading -> Civil Society Takes Charge On Climate Action As Governments Waver 21/09/2019 Elaine Ruth Fletcher NEW YORK CITY – Youth leaders from around the world clamored for more action on climate change Saturday at a first-ever United Nation’s Youth Climate Summit – even as the actual government commitments lined up for Monday’s formal meeting with heads of state appeared likely fall far short of making the dramatic changes that scientists […] Continue reading -> How To Fix The Medical R&D Model 14/08/2019 David Branigan Fifa Rahman, Unitaid NGO Delegation board member and PhD Candidate at the University of Leeds, moderated a panel at the recent IAS Conference on HIV Science in Mexico entitled “How To Fix Our Medical R&D Model: A Spotlight On TB Treatment.” The panel featured speakers from Médecins Sans Frontières’ (MSF/Doctors Without Borders) Access Campaign, Drugs […] Continue reading -> New Cancer Drugs Top Entries On WHO Essential Medicines List 09/07/2019 Editorial team, Elaine Ruth Fletcher & David Branigan WHO has added ten new cancer drugs, including some pricey ones, to its 2019 Essential Medicines List, which provides global guidance to countries and health systems about drugs deemed most essential to patients and public health systems. The addition of major new cancer treatments in five categories, melanoma (skin), lung, blood and prostate cancers, reflects […] Continue reading -> Major R&D Funding Needed To Reach 2030 Goal For Ending TB Epidemic 17/06/2019 Catherine Saez Nine months after a historic high-level UN meeting where countries pledged to end the global tuberculosis epidemic by 2030, a chronic lack of R&D financing jeopardises that ambitious goal, said expert panelists at a briefing on the TB R&D landscape last week in Geneva, hosted by South Africa’s Permanent Mission to the UN. While there […] Continue reading -> Draft UHC Declaration Strong On R&D Transparency, Weak On R&D Incentives Reform 14/06/2019 David Branigan In the lead-up to the United Nations High-Level Meeting on Universal Health Coverage (UHC) in September, the latest draft of a planned political declaration calls on member states to increase transparency of the cost of research and development (R&D) – in addition to drug prices – but falls short in the area of R&D incentive […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
More People In Low- and Middle-Income Countries Are Obese – While Others Remain Undernourished 16/12/2019 Grace Ren More than one-third of low- and middle-income countries worldwide are facing significant rates of obesity alongside continued pockets of undernutrition, according to a major new study published on Monday in The Lancet. The four-part series The Double Burden of Malnutrition, led by the World Health Organization in collaboration with a number of universities and researchers […] Continue reading -> Cancer Organizations Across Latin America Vow To Intensify Action Against Expected “Tsunami” Of New Cancer Deaths 05/12/2019 Editorial team For the first time ever, leading cancer organizations across Latin America have signed onto a joint declaration pledging to intensify action against millions of avoidable cancer deaths on the continent. The Bogota Statement on Leading BOLD Cancer Prevention into the Future was signed by leaders of cancer organizations and foundations from 8 Latin American countries, […] Continue reading -> Civil Society Takes Charge On Climate Action As Governments Waver 21/09/2019 Elaine Ruth Fletcher NEW YORK CITY – Youth leaders from around the world clamored for more action on climate change Saturday at a first-ever United Nation’s Youth Climate Summit – even as the actual government commitments lined up for Monday’s formal meeting with heads of state appeared likely fall far short of making the dramatic changes that scientists […] Continue reading -> How To Fix The Medical R&D Model 14/08/2019 David Branigan Fifa Rahman, Unitaid NGO Delegation board member and PhD Candidate at the University of Leeds, moderated a panel at the recent IAS Conference on HIV Science in Mexico entitled “How To Fix Our Medical R&D Model: A Spotlight On TB Treatment.” The panel featured speakers from Médecins Sans Frontières’ (MSF/Doctors Without Borders) Access Campaign, Drugs […] Continue reading -> New Cancer Drugs Top Entries On WHO Essential Medicines List 09/07/2019 Editorial team, Elaine Ruth Fletcher & David Branigan WHO has added ten new cancer drugs, including some pricey ones, to its 2019 Essential Medicines List, which provides global guidance to countries and health systems about drugs deemed most essential to patients and public health systems. The addition of major new cancer treatments in five categories, melanoma (skin), lung, blood and prostate cancers, reflects […] Continue reading -> Major R&D Funding Needed To Reach 2030 Goal For Ending TB Epidemic 17/06/2019 Catherine Saez Nine months after a historic high-level UN meeting where countries pledged to end the global tuberculosis epidemic by 2030, a chronic lack of R&D financing jeopardises that ambitious goal, said expert panelists at a briefing on the TB R&D landscape last week in Geneva, hosted by South Africa’s Permanent Mission to the UN. While there […] Continue reading -> Draft UHC Declaration Strong On R&D Transparency, Weak On R&D Incentives Reform 14/06/2019 David Branigan In the lead-up to the United Nations High-Level Meeting on Universal Health Coverage (UHC) in September, the latest draft of a planned political declaration calls on member states to increase transparency of the cost of research and development (R&D) – in addition to drug prices – but falls short in the area of R&D incentive […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Cancer Organizations Across Latin America Vow To Intensify Action Against Expected “Tsunami” Of New Cancer Deaths 05/12/2019 Editorial team For the first time ever, leading cancer organizations across Latin America have signed onto a joint declaration pledging to intensify action against millions of avoidable cancer deaths on the continent. The Bogota Statement on Leading BOLD Cancer Prevention into the Future was signed by leaders of cancer organizations and foundations from 8 Latin American countries, […] Continue reading -> Civil Society Takes Charge On Climate Action As Governments Waver 21/09/2019 Elaine Ruth Fletcher NEW YORK CITY – Youth leaders from around the world clamored for more action on climate change Saturday at a first-ever United Nation’s Youth Climate Summit – even as the actual government commitments lined up for Monday’s formal meeting with heads of state appeared likely fall far short of making the dramatic changes that scientists […] Continue reading -> How To Fix The Medical R&D Model 14/08/2019 David Branigan Fifa Rahman, Unitaid NGO Delegation board member and PhD Candidate at the University of Leeds, moderated a panel at the recent IAS Conference on HIV Science in Mexico entitled “How To Fix Our Medical R&D Model: A Spotlight On TB Treatment.” The panel featured speakers from Médecins Sans Frontières’ (MSF/Doctors Without Borders) Access Campaign, Drugs […] Continue reading -> New Cancer Drugs Top Entries On WHO Essential Medicines List 09/07/2019 Editorial team, Elaine Ruth Fletcher & David Branigan WHO has added ten new cancer drugs, including some pricey ones, to its 2019 Essential Medicines List, which provides global guidance to countries and health systems about drugs deemed most essential to patients and public health systems. The addition of major new cancer treatments in five categories, melanoma (skin), lung, blood and prostate cancers, reflects […] Continue reading -> Major R&D Funding Needed To Reach 2030 Goal For Ending TB Epidemic 17/06/2019 Catherine Saez Nine months after a historic high-level UN meeting where countries pledged to end the global tuberculosis epidemic by 2030, a chronic lack of R&D financing jeopardises that ambitious goal, said expert panelists at a briefing on the TB R&D landscape last week in Geneva, hosted by South Africa’s Permanent Mission to the UN. While there […] Continue reading -> Draft UHC Declaration Strong On R&D Transparency, Weak On R&D Incentives Reform 14/06/2019 David Branigan In the lead-up to the United Nations High-Level Meeting on Universal Health Coverage (UHC) in September, the latest draft of a planned political declaration calls on member states to increase transparency of the cost of research and development (R&D) – in addition to drug prices – but falls short in the area of R&D incentive […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Civil Society Takes Charge On Climate Action As Governments Waver 21/09/2019 Elaine Ruth Fletcher NEW YORK CITY – Youth leaders from around the world clamored for more action on climate change Saturday at a first-ever United Nation’s Youth Climate Summit – even as the actual government commitments lined up for Monday’s formal meeting with heads of state appeared likely fall far short of making the dramatic changes that scientists […] Continue reading -> How To Fix The Medical R&D Model 14/08/2019 David Branigan Fifa Rahman, Unitaid NGO Delegation board member and PhD Candidate at the University of Leeds, moderated a panel at the recent IAS Conference on HIV Science in Mexico entitled “How To Fix Our Medical R&D Model: A Spotlight On TB Treatment.” The panel featured speakers from Médecins Sans Frontières’ (MSF/Doctors Without Borders) Access Campaign, Drugs […] Continue reading -> New Cancer Drugs Top Entries On WHO Essential Medicines List 09/07/2019 Editorial team, Elaine Ruth Fletcher & David Branigan WHO has added ten new cancer drugs, including some pricey ones, to its 2019 Essential Medicines List, which provides global guidance to countries and health systems about drugs deemed most essential to patients and public health systems. The addition of major new cancer treatments in five categories, melanoma (skin), lung, blood and prostate cancers, reflects […] Continue reading -> Major R&D Funding Needed To Reach 2030 Goal For Ending TB Epidemic 17/06/2019 Catherine Saez Nine months after a historic high-level UN meeting where countries pledged to end the global tuberculosis epidemic by 2030, a chronic lack of R&D financing jeopardises that ambitious goal, said expert panelists at a briefing on the TB R&D landscape last week in Geneva, hosted by South Africa’s Permanent Mission to the UN. While there […] Continue reading -> Draft UHC Declaration Strong On R&D Transparency, Weak On R&D Incentives Reform 14/06/2019 David Branigan In the lead-up to the United Nations High-Level Meeting on Universal Health Coverage (UHC) in September, the latest draft of a planned political declaration calls on member states to increase transparency of the cost of research and development (R&D) – in addition to drug prices – but falls short in the area of R&D incentive […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
How To Fix The Medical R&D Model 14/08/2019 David Branigan Fifa Rahman, Unitaid NGO Delegation board member and PhD Candidate at the University of Leeds, moderated a panel at the recent IAS Conference on HIV Science in Mexico entitled “How To Fix Our Medical R&D Model: A Spotlight On TB Treatment.” The panel featured speakers from Médecins Sans Frontières’ (MSF/Doctors Without Borders) Access Campaign, Drugs […] Continue reading -> New Cancer Drugs Top Entries On WHO Essential Medicines List 09/07/2019 Editorial team, Elaine Ruth Fletcher & David Branigan WHO has added ten new cancer drugs, including some pricey ones, to its 2019 Essential Medicines List, which provides global guidance to countries and health systems about drugs deemed most essential to patients and public health systems. The addition of major new cancer treatments in five categories, melanoma (skin), lung, blood and prostate cancers, reflects […] Continue reading -> Major R&D Funding Needed To Reach 2030 Goal For Ending TB Epidemic 17/06/2019 Catherine Saez Nine months after a historic high-level UN meeting where countries pledged to end the global tuberculosis epidemic by 2030, a chronic lack of R&D financing jeopardises that ambitious goal, said expert panelists at a briefing on the TB R&D landscape last week in Geneva, hosted by South Africa’s Permanent Mission to the UN. While there […] Continue reading -> Draft UHC Declaration Strong On R&D Transparency, Weak On R&D Incentives Reform 14/06/2019 David Branigan In the lead-up to the United Nations High-Level Meeting on Universal Health Coverage (UHC) in September, the latest draft of a planned political declaration calls on member states to increase transparency of the cost of research and development (R&D) – in addition to drug prices – but falls short in the area of R&D incentive […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
New Cancer Drugs Top Entries On WHO Essential Medicines List 09/07/2019 Editorial team, Elaine Ruth Fletcher & David Branigan WHO has added ten new cancer drugs, including some pricey ones, to its 2019 Essential Medicines List, which provides global guidance to countries and health systems about drugs deemed most essential to patients and public health systems. The addition of major new cancer treatments in five categories, melanoma (skin), lung, blood and prostate cancers, reflects […] Continue reading -> Major R&D Funding Needed To Reach 2030 Goal For Ending TB Epidemic 17/06/2019 Catherine Saez Nine months after a historic high-level UN meeting where countries pledged to end the global tuberculosis epidemic by 2030, a chronic lack of R&D financing jeopardises that ambitious goal, said expert panelists at a briefing on the TB R&D landscape last week in Geneva, hosted by South Africa’s Permanent Mission to the UN. While there […] Continue reading -> Draft UHC Declaration Strong On R&D Transparency, Weak On R&D Incentives Reform 14/06/2019 David Branigan In the lead-up to the United Nations High-Level Meeting on Universal Health Coverage (UHC) in September, the latest draft of a planned political declaration calls on member states to increase transparency of the cost of research and development (R&D) – in addition to drug prices – but falls short in the area of R&D incentive […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Major R&D Funding Needed To Reach 2030 Goal For Ending TB Epidemic 17/06/2019 Catherine Saez Nine months after a historic high-level UN meeting where countries pledged to end the global tuberculosis epidemic by 2030, a chronic lack of R&D financing jeopardises that ambitious goal, said expert panelists at a briefing on the TB R&D landscape last week in Geneva, hosted by South Africa’s Permanent Mission to the UN. While there […] Continue reading -> Draft UHC Declaration Strong On R&D Transparency, Weak On R&D Incentives Reform 14/06/2019 David Branigan In the lead-up to the United Nations High-Level Meeting on Universal Health Coverage (UHC) in September, the latest draft of a planned political declaration calls on member states to increase transparency of the cost of research and development (R&D) – in addition to drug prices – but falls short in the area of R&D incentive […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Draft UHC Declaration Strong On R&D Transparency, Weak On R&D Incentives Reform 14/06/2019 David Branigan In the lead-up to the United Nations High-Level Meeting on Universal Health Coverage (UHC) in September, the latest draft of a planned political declaration calls on member states to increase transparency of the cost of research and development (R&D) – in addition to drug prices – but falls short in the area of R&D incentive […] Continue reading -> Posts navigation Older posts